Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

New video on the Market Access Insider Youtube channel: Interview with Andrea Zanella about IVD market in Italy

MTRC has released the new video on the Market Access Insider Youtube channel. Oleg Borisenko spoke to Mr. Andrea Zanella, CEO of DIANAX S.r.l. about market access for in-vitro diagnostic tests in Italy.

DIANAX S.r.l. is an Italian-French international company that works in the IVD Point-of-Care testing field, and it is directly involved in the COVID-19 emergency with its COVID-AITM system of quantitative IgG / IgM Serological Tests with Artificial Intelligence, in collaboration with BioSpeedia SAS, a spin-off of the Institut Pasteur.

Andrea is also a former vice-chairman of the Italian Med Tech Industry Association – Confindustria Dispositivi Medici (previously ASSOBIOMEDICA).

The interview covered the specifics of market access for in-vitro diagnostic tests, the role of national and regional stakeholders, the role of health technology assessment in market access for IVD tests, and the role of industry in market access activities.

The interview was recorded in April 2019.

Watch the interview here.